These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30014218)

  • 41. Association between neck ultrasonographic findings and clinico-pathological features in the follicular variant of papillary thyroid carcinoma.
    Jang EK; Kim WG; Choi YM; Jeon MJ; Kwon H; Baek JH; Lee JH; Kim TY; Shong YK; Song DE; Kim WB
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):968-76. PubMed ID: 25400279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O
    Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytopathology of Solid Variant of Papillary Thyroid Carcinoma: Differential Diagnoses with other Thyroid Tumors.
    Guleria P; Phulware R; Agarwal S; Jain D; Mathur SR; Iyer VK; Ballal S; Bal CS
    Acta Cytol; 2018; 62(5-6):371-379. PubMed ID: 30253413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytomorphological Analysis of Thyroid Nodules Diagnosed as Follicular Variant of Papillary Thyroid Carcinoma: a Fine Needle Aspiration Study of Diagnostic Clues in 42 Cases and the Impact of Using Bethesda System in Reporting-an Institutional Experience.
    Trabzonlu L; Paksoy N
    Endocr Pathol; 2018 Dec; 29(4):351-356. PubMed ID: 30315491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.
    Schneider DF; Elfenbein D; Lloyd RV; Chen H; Sippel RS
    Ann Surg Oncol; 2015 Jan; 22(1):158-63. PubMed ID: 25092163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do patients with oxyphilic cell papillary thyroid carcinoma have a poor prognosis? Analysis of the surveillance, epidemiology, and end results database 2004-2013 with propensity score matching.
    Liu C; Zhao Q; Zeng W; Chen C; Ming J; Wang S; Xiong Y; Zhang C; Chen T; Liu Z; Huang T
    Oncotarget; 2017 Sep; 8(44):77075-77085. PubMed ID: 29100371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Avidity and Outcomes of Radioiodine Therapy for Distant Metastasis of Distinct Types of Differentiated Thyroid Cancer.
    Simões-Pereira J; Mourinho N; Ferreira TC; Limbert E; Cavaco BM; Leite V
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3911-e3922. PubMed ID: 34134139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers.
    Ertek S; Yılmaz NC; Cicero AF; Vurupalmaz Ö; Demiröz AS; Erdoğan G
    Endocr Pathol; 2012 Sep; 23(3):157-60. PubMed ID: 22711546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma.
    John D; Yalamarty R; Barakchi A; Chen T; Chakladar J; Li WT; Ongkeko WM
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Columnar cell papillary thyroid carcinoma prognosis: findings from the SEER database using propensity score matching analysis.
    Wang S; Xiong Y; Zhao Q; Song H; Yi P; Liu C
    Am J Transl Res; 2019; 11(9):6262-6270. PubMed ID: 31632592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.
    Wreesmann VB; Ghossein RA; Hezel M; Banerjee D; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
    Genes Chromosomes Cancer; 2004 Aug; 40(4):355-64. PubMed ID: 15188460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
    Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
    [No Abstract]   [Full Text] [Related]  

  • 53. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
    Zou M; Baitei EY; Alzahrani AS; BinHumaid FS; Alkhafaji D; Al-Rijjal RA; Meyer BF; Shi Y
    Thyroid; 2014 Aug; 24(8):1256-66. PubMed ID: 24798740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status.
    Walts AE; Mirocha JM; Bose S
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1749-56. PubMed ID: 25702102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical utility of KAP-1 expression in thyroid lesions.
    Martins MB; Marcello MA; Morari EC; Cunha LL; Soares FA; Vassallo J; Ward LS
    Endocr Pathol; 2013 Jun; 24(2):77-82. PubMed ID: 23645532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin.
    Nilubol N; Zhang L; Kebebew E
    Thyroid; 2013 Jun; 23(6):695-702. PubMed ID: 23194434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
    Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
    Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer.
    Sullivan MC; Graham PH; Alexander EK; Ruan DT; Nehs MA; Gawande AA; Moore FD; Howitt BE; Strickland KC; Krane JF; Barletta JA; Cho NL
    J Am Coll Surg; 2017 Jun; 224(6):1021-1027. PubMed ID: 28017809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
    Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
    Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
    Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.